Rani Therapeutics Holdings, Inc.
RANI
$0.6244
$0.075813.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.87% | 18.81% | -31.90% | 0.32% | 9.06% |
| Total Depreciation and Amortization | -4.38% | -5.64% | 2.70% | 1.57% | 2.82% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 49.43% | -211.09% | 185.40% | 50.80% | 22.73% |
| Change in Net Operating Assets | 4,242.86% | 102.47% | -72.56% | -909.88% | -93.04% |
| Cash from Operations | 28.87% | 5.85% | -2.91% | 6.86% | 3.97% |
| Capital Expenditure | 27.45% | -64.52% | 75.20% | -32.98% | -422.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.54% | 616.30% | 329.63% | -91.03% | -35.81% |
| Cash from Investing | -68.66% | 623.09% | 437.53% | -92.81% | -36.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -200.00% | -- | -- |
| Issuance of Common Stock | 9,295.24% | -99.55% | 4.57% | 5,335.15% | 36.36% |
| Repurchase of Common Stock | 65.22% | -155.56% | 35.71% | 41.67% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 105.04% | -166.40% | -27.06% | 5,363.83% | 16.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.35% | 1,332.82% | -117.30% | 89.97% | -333.27% |